U.S. pharma huge copyright scrapped two experimental weight loss capsules final calendar year—a as soon as-day-to-day capsule, lotiglipron, as a result of elevated liver enzymes plus a 2 times-daily pill, danuglipron, because of solid Uncomfortable side effects—but CEO Albert Bourla has said the company is decided to “Participate in and earn�